MSH2 Gene Mismatch Repair Cancer Syndrome Genetic Test
Welcome to DNA Labs UAE, where we offer advanced genetic testing services. Today, we will be discussing the MSH2 gene mismatch repair cancer syndrome genetic test.
Test Details
The MSH2 gene mismatch repair cancer syndrome is a hereditary condition that increases the risk of developing certain types of cancer, particularly colorectal and endometrial cancer. This syndrome is caused by mutations in the MSH2 gene, which plays a crucial role in DNA mismatch repair.
Our genetic test utilizes Next-Generation Sequencing (NGS) technology, which allows for the analysis of multiple genes simultaneously. By examining the MSH2 gene, we can detect any mutations or variations that may be associated with cancer susceptibility.
Test Components and Price
- Test Name: MSH2 Gene Mismatch Repair Cancer Syndrome Genetic Test
- Price: 4400.0 AED
Sample Condition
We require a blood sample, extracted DNA, or one drop of blood on an FTA card for this test.
Report Delivery
Once the sample is received, the report will be delivered within 3 to 4 weeks.
Test Method
We utilize NGS technology for this genetic test.
Test Type
The MSH2 gene mismatch repair cancer syndrome genetic test falls under the category of cancer testing.
Doctor
An oncologist will oversee the test.
Test Department
This test is conducted in our Genetics department.
Pre Test Information
Prior to the MSH2 gene mismatch repair cancer syndrome genetic test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by this syndrome.
Test Process
The MSH2 gene mismatch repair cancer syndrome genetic test involves obtaining a DNA sample, typically through a blood sample or cheek swab. This DNA is then sequenced using NGS technology to identify any mutations or variations in the MSH2 gene.
The test results can help determine an individual’s risk of developing cancer and guide personalized screening and management recommendations.
It is important to note that this test is usually recommended for individuals with a personal or family history suggestive of hereditary cancer syndrome. Genetic counseling is often advised before and after testing to discuss the implications of the results and help individuals make informed decisions about their healthcare.
Always consult with a healthcare professional or genetic counselor to discuss the specific indications, benefits, and limitations of the MSH2 gene mismatch repair cancer syndrome genetic test in individual cases.
| Test Name | MSH2 Gene Mismatch repair cancer syndrome Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MSH2 Gene Mismatch repair cancer syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MSH2 Gene Mismatch repair cancer syndrome NGS Genetic DNA Test gene MSH2 |
| Test Details | MSH2 gene mismatch repair cancer syndrome is a hereditary condition that increases the risk of developing certain types of cancer, particularly colorectal and endometrial cancer. It is caused by mutations in the MSH2 gene, which is involved in DNA mismatch repair. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. It allows for the detection of mutations or variations in genes, including the MSH2 gene, that may be associated with cancer susceptibility. NGS genetic testing for MSH2 gene mismatch repair cancer syndrome involves obtaining a DNA sample, usually through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the MSH2 gene. The results of the test can help determine an individual’s risk of developing cancer and guide personalized screening and management recommendations. It is important to note that NGS genetic testing for MSH2 gene mismatch repair cancer syndrome is typically recommended for individuals with a personal or family history suggestive of hereditary cancer syndrome. Genetic counseling is often recommended before and after testing to discuss the implications of the test results and to help individuals make informed decisions about their healthcare. It is always advisable to consult with a healthcare professional or genetic counselor to discuss the specific indications, benefits, and limitations of NGS genetic testing for MSH2 gene mismatch repair cancer syndrome in individual cases. |
